Literature DB >> 24718935

A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression.

Pelagia Foka1, Alexios Dimitriadis, Eleni Kyratzopoulou, Dionysios A Giannimaras, Stefania Sarno, George Simos, Urania Georgopoulou, Avgi Mamalaki.   

Abstract

Hepatitis C virus (HCV) infection is associated with hepatic iron overload and elevated serum iron that correlate to poor antiviral responses. Hepcidin (HAMP), a 25-aa cysteine-rich liver-specific peptide, controls iron homeostasis. Its expression is up-regulated in inflammation and iron excess. HCV-mediated hepcidin regulation remains controversial. Chronic HCV patients possess relatively low hepcidin levels; however, elevated HAMP mRNA has been reported in HCV core transgenic mice and HCV replicon-expressing cells. We investigated the effect of HCV core protein on HAMP gene expression and delineated the complex interplay of molecular mechanisms involved. HCV core protein up-regulated HAMP promoter activity, mRNA, and secreted protein levels. Enhanced promoter activity was abolished by co-transfections of core with HAMP promoter constructs containing mutated/deleted BMP and STAT binding sites. Dominant negative constructs, pharmacological inhibitors, and silencing experiments against STAT3 and SMAD4 confirmed the participation of both pathways in HAMP gene regulation by core protein. STAT3 and SMAD4 expression levels were found increased in the presence of HCV core, which orchestrated SMAD4 translocation into the nucleus and STAT3 phosphorylation. To further understand the mechanisms governing the core effect, the role of the JAK/STAT-activating kinase CK2 was investigated. A CK2-dominant negative construct, a CK2-specific inhibitor, and RNAi interference abrogated the core-induced increase on HAMP promoter activity, mRNA, and protein levels, while CK2 acted in synergy with core to significantly enhance HAMP gene expression. Therefore, HCV core up-regulates HAMP gene transcription via a complex signaling network that requires both SMAD/BMP and STAT3 pathways and CK2 involvement.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24718935     DOI: 10.1007/s00018-014-1621-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  100 in total

1.  Regulation of protein phosphatase 2A by direct interaction with casein kinase 2alpha.

Authors:  J K Hériché; F Lebrin; T Rabilloud; D Leroy; E M Chambaz; Y Goldberg
Journal:  Science       Date:  1997-05-09       Impact factor: 47.728

2.  Regulatory failure of serum prohepcidin levels in patients with hepatitis C.

Authors:  Miki Nagashima; Masatoshi Kudo; Hobyung Chung; Emi Ishikawa; Satoru Hagiwara; Tatsuya Nakatani; Kensaku Dote
Journal:  Hepatol Res       Date:  2006-09-18       Impact factor: 4.288

3.  Interleukin-6 induces hepcidin expression through STAT3.

Authors:  Diedra M Wrighting; Nancy C Andrews
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

4.  Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein.

Authors:  Elizabeta Nemeth; Erika V Valore; Mary Territo; Gary Schiller; Alan Lichtenstein; Tomas Ganz
Journal:  Blood       Date:  2002-11-14       Impact factor: 22.113

5.  Sustained submicromolar H2O2 levels induce hepcidin via signal transducer and activator of transcription 3 (STAT3).

Authors:  Gunda Millonig; Ingo Ganzleben; Teresa Peccerella; Guillem Casanovas; Lidia Brodziak-Jarosz; Katja Breitkopf-Heinlein; Tobias P Dick; Helmut-Karl Seitz; Martina U Muckenthaler; Sebastian Mueller
Journal:  J Biol Chem       Date:  2012-08-29       Impact factor: 5.157

6.  Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.

Authors:  E Tsochatzis; G V Papatheodoridis; V Koliaraki; E Hadziyannis; G Kafiri; E K Manesis; A Mamalaki; A J Archimandritis
Journal:  J Viral Hepat       Date:  2010-11       Impact factor: 3.728

7.  Iron regulatory and bactericidal properties of human recombinant hepcidin expressed in Pichia pastoris.

Authors:  Vasiliki Koliaraki; Martha Marinou; Martina Samiotaki; George Panayotou; Kostas Pantopoulos; Avgi Mamalaki
Journal:  Biochimie       Date:  2008-02-06       Impact factor: 4.079

8.  Bone morphogenetic protein (BMP)-responsive elements located in the proximal and distal hepcidin promoter are critical for its response to HJV/BMP/SMAD.

Authors:  Guillem Casanovas; Katarzyna Mleczko-Sanecka; Sandro Altamura; Matthias W Hentze; Martina U Muckenthaler
Journal:  J Mol Med (Berl)       Date:  2009-02-20       Impact factor: 4.599

9.  Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2.

Authors:  Giorgio Cozza; Marco Mazzorana; Elena Papinutto; Jenny Bain; Matthew Elliott; Giovanni di Maira; Alessandra Gianoncelli; Mario A Pagano; Stefania Sarno; Maria Ruzzene; Roberto Battistutta; Flavio Meggio; Stefano Moro; Giuseppe Zagotto; Lorenzo A Pinna
Journal:  Biochem J       Date:  2009-07-15       Impact factor: 3.857

10.  C/EBPalpha regulates hepatic transcription of hepcidin, an antimicrobial peptide and regulator of iron metabolism. Cross-talk between C/EBP pathway and iron metabolism.

Authors:  Brice Courselaud; Christelle Pigeon; Yusuke Inoue; Junko Inoue; Frank J Gonzalez; Patricia Leroyer; David Gilot; Karim Boudjema; Christiane Guguen-Guillouzo; Pierre Brissot; Olivier Loréal; Gennady Ilyin
Journal:  J Biol Chem       Date:  2002-08-14       Impact factor: 5.157

View more
  8 in total

1.  Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.

Authors:  Pelagia Foka; Alexios Dimitriadis; Eirini Karamichali; Eleni Kyratzopoulou; Dionyssios Giannimaras; John Koskinas; Agoritsa Varaklioti; Avgi Mamalaki; Urania Georgopoulou
Journal:  Virulence       Date:  2016-04-08       Impact factor: 5.882

Review 2.  Iron-Induced Hepatocarcinogenesis-Preventive Effects of Nutrients.

Authors:  Hiroyuki Tsuchiya
Journal:  Front Oncol       Date:  2022-06-27       Impact factor: 5.738

Review 3.  The cGAS-STING Pathway: Novel Perspectives in Liver Diseases.

Authors:  Dongwei Xu; Yizhu Tian; Qiang Xia; Bibo Ke
Journal:  Front Immunol       Date:  2021-04-29       Impact factor: 8.786

4.  The importance of negative determinants as modulators of CK2 targeting. The lesson of Akt2 S131.

Authors:  Jordi Vilardell; Cristina Girardi; Oriano Marin; Giorgio Cozza; Lorenzo A Pinna; Maria Ruzzene
Journal:  PLoS One       Date:  2018-03-01       Impact factor: 3.240

Review 5.  The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design.

Authors:  Giorgio Cozza
Journal:  Pharmaceuticals (Basel)       Date:  2017-02-20

6.  Inflammasomes and their roles in the pathogenesis of viral hepatitis and their related complications: An updated systematic review.

Authors:  Maryam Dadmanesh; Mohammad Mehdi Ranjbar; Khodayar Ghorban
Journal:  Immunol Lett       Date:  2019-03-01       Impact factor: 3.685

7.  The Selectivity of CK2 Inhibitor Quinalizarin: A Reevaluation.

Authors:  Giorgio Cozza; Andrea Venerando; Stefania Sarno; Lorenzo A Pinna
Journal:  Biomed Res Int       Date:  2015-10-19       Impact factor: 3.411

8.  The Hepatitis C virus NS5A and core proteins exert antagonistic effects on HAMP gene expression: the hidden interplay with the MTF-1/MRE pathway.

Authors:  Alexios Dimitriadis; Pelagia Foka; Eleni Kyratzopoulou; Eirini Karamichali; Stavroula Petroulia; Panagiota Tsitoura; Athanasios Kakkanas; Petros Eliadis; Urania Georgopoulou; Avgi Mamalaki
Journal:  FEBS Open Bio       Date:  2020-12-13       Impact factor: 2.792

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.